FindMyKOL

Lorna Brudie, DO

Basic profile

Orlando Health

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionOrlando, FL · SoutheastSpecialtyGynecologic OncologyFocusOncology
Last active 2024FindMyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Lorna Brudie is an Oncology physician affiliated with Orlando Health. OpenAlex indexes 25 publications with 493 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
25publications

Publications indexed by OpenAlex. Counts exclude supporting files.

493citations

Citations across these publications.

10h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
13companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Myriad Genetic Laboratories, Inc.
    Program year20244 payments
    $222
  • CONMED Corporation
    Program year20242 payments
    $200
  • Hologic Sales and Service, LLC
    Program year20241 payment
    $140
All 15 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    31.5%
    Prostaglandin E1 Analog31.5%
    Misoprostol100%
    Part D≥25 patients
  • Genitourinary & hormones

    29.3%
    Progestin17.4%
    Megestrol Acetate100%
    Part D<11 patients
    Estrogen12%
    Estradiol100%
    Part D<11 patients
  • Nervous system

    14.1%
    Gabapentinoids14.1%
    Gabapentin100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”